pharmaceutical investing Foamix Reports First Quarter 2018 Financial Results and Provides Corporate Update
pharmaceutical investing VBL Therapeutics Announces Top-Line Results from Pivotal Phase 3 GLOBE Study
pharmaceutical investing Melinta Therapeutics Publishes Complete Results from Phase 3 TANGO I Study of VABOMERE
pharmaceutical investing Intercept Announces Phase 3 REVERSE Trial Evaluating OCA for the Treatment of NASH Patients
80 Mile PLC Secures 3 Strategic MOUs with Fortune 500 Energy Group, Ludoil, and JEnergy and moves to 100% of Ferrandina Biofuels Plant
Cotec Purchases Commercial Scale Salter Cyclone Multi-Gravity-Separator Unit to be Located at Corem Québec, Canada
TSX-V: TT Closes Acquisition of High Lake and West Hawk Lake from McFarlane Lake Mining and Closing of Final Tranche of Non-Brokered Private Placement
Element One Hydrogen and Critical Minerals Announces Letter of Intent to Acquire Hydrogen and Critical Mineral Extraction Technology
